Elon Musk closer to becoming first-ever trillionaire as he marks major milestone

The Delaware Supreme Court reinstated Elon Musk's 2018 Tesla stock options, restoring roughly $139bn of compensation and propelling his Forbes-estimated net worth to $749bn. If exercised, the options would boost Musk's stake from ~12.4% to ~18.1% on an expanded share base; Tesla is currently valued at $1.51trn. The ruling reduces legal overhang for Tesla and revives a large potential dilution/demand dynamic for shares, coming shortly after a separate November-approved pay plan that could award Musk >400m shares (worth up to ~$1trn) if aggressive production, robotaxi, subscription and profit milestones are met.

Analysis

Market structure: The Delaware ruling materially strengthens Musk's upside optionality and investor sentiment toward TSLA, reducing immediate governance uncertainty and likely lifting implied demand for Tesla shares over days–weeks (expect a 3–8% news-driven re-rating). Direct beneficiaries: TSLA holders, Tesla option writers (higher IV), and suppliers tied to volume (STM suppliers, e.g., ALSP/auto supply chain); losers: short sellers, smaller EV peers whose narrative is now compared unfavorably to Musk's aggregated incentives.

Risk assessment: Tail risks include renewed shareholder litigation or SEC scrutiny, dilution shock if >5–10% incremental shares are issued rapidly, or operational failure on robotaxi/subscription targets; probability low-to-moderate but asymmetric given $400bn profit and 20m vehicle targets. Time buckets: immediate (1–10 days) = volatility spike and gamma flows; short-term (1–6 months) = delivery numbers and S-8 filings; long-term (1–5 years) = realization of robotaxi/AI revenue streams that justify $8.5trn market cap.

Trade implications: Favored tactical play is calibrated bullish exposure to TSLA balanced with tail protection: enter 2–3% portfolio long equity or equivalent via 12-month call spread (25–35% OTM) to cap cost, and buy 30–50% notional downside protection via 6–12 month puts. Relative trades: long TSLA vs short NIO (NIO) or RIVN (RIVN) on execution and China/regulatory divergence; expect relative outperformance if Tesla converts incentives into Robotaxi progress.

Contrarian angles: Consensus underweights dilution and insider selling risks — reinstated options could trigger staged option exercises and share issuance that compresses near-term EPS by mid-single-digit percentage points. Historical parallels (large CEO pay reinstatements) show short-term rallies followed by multi-quarter mean reversion if operational milestones slip; watch share count and S-8 amendments in next 10 trading days as the pivotal data point.

Key Decisions for Investors

• Establish a 2–3% net-long position in TSLA (ticker: TSLA) within 1–5 trading days via a 12‑month call spread (buy Jan 2027 30% OTM call, sell Jan 2027 60% OTM call) to capture upside while capping premium; allocate max 3% portfolio risk.
• Hedge the position with 30–50% notional protection: buy 6–12 month puts at ~20% OTM (e.g., 6–12 month TSLA 20% OTM puts) to limit tail loss while events (S‑8 filings, Q4 deliveries) resolve over next 3 months.
• Implement a pair trade: long TSLA equal-dollar vs short NIO (NIO) for 0.6x notional (e.g., $1 long TSLA funded by $0.6 short NIO) — target relative return +15% if Tesla confirms Robotaxi progress within 12 months; rebalance after quarterly results.
• Reduce or avoid new long positions in small/high-multiple EV peers (RIVN, LI, NIO) by 1–2% portfolio until share-count impact is clarified; if Tesla S‑8/amendment shows >5% immediate dilution, trim broader EV exposure by additional 1–2% within 10 trading days.